News

In the study, which was conducted at the University of Chicago, patients in the intervention group were monitored with EarlySense's sleep monitor instead of being woken up for nightly vital checks. 

The company will be listing its shares on the Nasdaq exchange, and has hired Barclays, Goldman Sachs and JP Morgan as its underwriters.

Also: Study uses VR to explore autism spectrum disorder brain activity; UPS eyeing in-home healthcare.

The Eversense Bridge program is geared toward patients with high-deductible insurance plans or plans that don't cover the full cost of Eversense CGM, and allows them to purchase the system for $99. 

Researchers found that 64 percent of mental health apps claimed efficacy, although only 14 percent included any evidence.

Researchers noted transmissions of specific sensitive data, such as a user’s drug list, that could de-identify the user and be repurposed for commercial uses.

Whether by managing payments, connecting consumers to reimbursement options or just manufacturing cheap drugs themselves, these companies are taking aim at a problem that's building to a crisis.

The free game evokes inflamed organs, tar-filled pits and other jarring imagery to drive home its metaphor for smoking's side effects.

Partner AliveCor also got a mysterious new FDA clearance.

In a small study published in PLOS ONE, 80 percent of participants using a surrogate robot achieved clinically meaningful improvement on a modified version of the Action Research Arm Test.